Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 inter alia to consider and approve unaudited standalone and consolidated quarterly results 31.12.2025 on 25.02.2026
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]